01Clinical context
What is the finding?
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
Medical Skin Care for Acne · Medical Skin Care · Istanbul
Medical Skin Care for Acne · Medical Skin Care · Istanbul
Medical Skin Care for Acne
Cleansing and cosmetic care do not replace medical acne treatment. A named care method, ingredient or infusion is not a diagnosis and does not establish personal suitability.
Online information cannot diagnose, select products or procedures, or promise an outcome. Final decisions require an in-person medical assessment.
Clinical Orientation
Finding · identity · evidence · safety
Four questions precede a personal plan.
The sequence prevents a category name from becoming an automatic treatment recommendation.
02Identity
What exactly is proposed?
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
03Evidence
What does the evidence support?
Skin-care evidence must be read alongside acne severity and any disease-directed treatment.
04Safety
When should it stop?
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
What is Medical Skin Care for Acne?
Basic routine · Active ingredient · Treatment support
Acne skin care supports treatment — it is not the treatment for every form of acne.
Medical acne skin care is a low-irritation, non-comedogenic foundation of cleansing, moisturising and photoprotection that supports appropriate acne treatment. It is not cosmetic deep cleansing.
What Medical Skin Care for Acne can do
- Identify irritating or comedogenic contributors in the current routine
- Reduce dryness and barrier symptoms during acne treatment in a targeted way
- Structure an active-ingredient plan clearly, sparingly and practically for daily life
- Compare tolerance, new lesions and pigment marks at defined times
What Medical Skin Care for Acne cannot do
- Remove comedones or inflammation by scrubbing, frequent washing or drying the skin
- Replace necessary treatment for inflammatory, nodular or scarring acne on its own
- Combine multiple acids, retinoids and peels safely without an interaction plan
- Remove established scars or guarantee permanently flawless skin
Skin care is one part of the plan. With inflammatory activity, deep nodules, scarring risk or substantial psychological burden, it must not delay necessary medical treatment.
Medical Suitability
Diagnosis and activity before care
Five checks come before selection.
History, examination, current treatment, contraindications and a proportionate alternative are reviewed together.
- 01
Clarify the problem
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
- 02
Review current treatment
Medicines, allergies, previous procedures or infusions and relevant reactions are considered.
- 03
Identify the exact option
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
- 04
Compare alternatives
Medical acne assessment, prescribed treatment where appropriate, simple non-irritating care, observation or referral
- 05
Plan follow-up
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Care Path
Before · during · after
Safety depends on a complete, documented chain.
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
01Before
Confirm finding and skin state
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
- Review history and examination
- Check contraindications
- Keep alternatives open
02During
Control exposure and response
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
- Maintain traceability
- Monitor tolerance
- Stop when safety changes
03After
Separate expected response from harm
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
- Record observations
- Explain warning signs
- Provide a review route
No personal acid concentration, contact time, prescription medicine or home-treatment recipe is published.
Evidence and Limits
Method-, product- and indication-specific
Biology or popularity is not proof of clinical benefit.
Skin-care evidence must be read alongside acne severity and any disease-directed treatment.
Keep the indication exact
Evidence in one diagnosis or deficiency does not establish a general effect.
Keep the intervention exact
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
Keep endpoints separate
Symptoms, photographs, laboratory values and patient-reported outcomes are not interchangeable.
Retain uncertainty
A cosmetic extraction or cleansing session cannot diagnose or treat every form of acne.
Manufacturer information may identify a product and instructions, but it is not treated as independent evidence of a general class effect.
Individual Plan
Stable foundation before another active ingredient
The plan starts with a sustainable foundation.
Cleansing, moisturising and photoprotection are stabilised; no more than one new treatment step is then added.
Clear the inventory
Stop unnecessary acids, peels, oils and frequent product changes.
Set the foundation
Choose a cleanser, moisturiser and sunscreen suited to the barrier.
Add an active ingredient
Begin only one justified step with clear instructions for use.
Use the review point
Review lesions, irritation, pigmentation and adherence together.
Course and Follow-Up
Expected response · complication · reassessment
Repetition is never automatic.
Tolerance and the agreed clinical endpoint are reviewed separately before any further intervention.
- 01Before
Baseline
Record the starting clinical context and intended endpoint.
- 02Same day
Immediate review
Observe tolerance and unexpected reactions.
- 03Later
Clinical review
Compare the relevant finding without automatic attribution.
- 04Decision
Continue, change or stop
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Risks and Alternatives
Do not confuse irritation with effectiveness
Burning and peeling are not measures of quality.
Possible harms include irritant or allergic dermatitis, dryness, photosensitivity, unsuitable use during pregnancy and delayed treatment of scarring acne.
01Acne
Escalate in time
Deep painful nodules, new scars or rapid worsening need medical acne treatment.
02Safety
Check pregnancy
Retinoids and other active ingredients must not be used without reviewing pregnancy and breastfeeding.
03Barrier
Limit the irritant load
Acids, retinoids, peels, brushes and alcohol-rich products are not stacked without a plan.
04Acute
Recognise warning signs
Blisters, severe swelling, pus, fever or spreading redness require local examination.
An online message is not enough for worsening inflammation, an allergic reaction or suspected infection. Timely examination where the patient is located is then necessary.
Istanbul and Follow-Up
Assessment and review must travel together
International care needs a workable safety route.
Travel does not shorten observation or remove the need for local medical access.
01
Organise the question
History and existing records prepare discussion without confirming treatment.
02
Assess in person
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
03
Keep exact records
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
04
Plan escalation
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
The Doctor Aslan Approach
Medical position
The best acne routine is not the longest.
Dr İsmail Aslan organises acne care by lesion type, degree of inflammation, barrier condition, medicines and daily life. The aim is a clear routine that supports necessary treatment and recognises its own limits in time.
Lesion before trend
The diagnosis determines the step; a viral product video does not replace an acne assessment.
Barrier in the plan
Tolerance is part of effectiveness, not an afterthought about comfort.
One change at a time
New products are introduced so that benefit or irritation can be attributed.
Escalate treatment in time
Scarring risk, deep nodules or treatment failure move care beyond a skin-care routine alone.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about Medical Skin Care for Acne; no personal prescription or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01Is skin care enough to treat acne?+
A gentle, non-comedogenic foundation can improve barrier function and tolerance, but does not adequately treat every form of acne. Inflammatory lesions, deep nodules, new scars or persistent acne may require appropriate topical, hormonal or systemic treatment. Skin care supports this plan and must not delay it.
02What does ‘non-comedogenic’ mean for skin care and sunscreen?+
The label means a formulation is expected not to clog pores, or to do so less often. It is not a guarantee for every person and says nothing about tolerance of other ingredients. Product, applied amount, contact region and actual course are assessed together.
03Is an initial worsening always normal ‘purging’?+
No. Some active ingredients can make the course more visible, but ‘purging’ must not be used to explain away severe inflammation, eczema, blisters, swelling or new lesions outside usual acne areas. Type, timing and region of the reaction must be assessed; with marked symptoms, treatment is paused and medically reviewed.
04How is an acne routine planned for travel to Istanbul?+
Photographs, course, full product names with INCI, medicines, previous reactions and pregnancy planning can be organised online. Lesion type and severity are examined in person; morning and evening routines, active-ingredient introduction, review date, product access at home and local medical follow-up are clarified before return travel.
Next Step
Define the question · verify the option · compare alternatives